FB04: Psychologie
Permanent URI for this communityhttps://data.uni-marburg.de/handle/dataumr/474
Browse
Research Data Open Access A Bayesian Model for Chronic Pain.Eckert, Anna-Lena; Endres, Dominik; Pabst, KathrinResearch Data Open Access A collection of identities for variational inference with exponential-family modelsEndres, Dominik; Pabst, Kathrin; Eckert, Anna-Lena; Schween, RaphaelResearch Data Open Access A Model for Optic Flow Integration in Locust Central-Complex Neurons Tuned to Head Direction(Kathrin Pabst) Pabst, Kathrin; Zittrell, Frederick; Endres, Dominik; Homberg, UweResearch Data Open Access Distracted by Previous Experience: Integrating Selection History, Current Task Demands and Saliency in an Algorithmic Model- Springer2024(Philipps-Universität marburg, 07.05.2021) Endres, Dominik; Meibodi, Neda; Meibodi, NedaThis repository contains the files and data necessary to recreate the results from the paper Meibodi, N., Abbasi, H., Schubö, A. et al. Distracted by Previous Experience: Integrating Selection History, Current Task Demands and Saliency in an Algorithmic Model. Comput Brain Behav 7, 268–285 (2024). https://doi.org/10.1007/s42113-024-00197-6 Please go to Version 2 if you are interested to see the files related to the other pubplication N.Meibodi, H.Abbasi, A. Schuboe, D. Endres (2021) A Model of Selection History in Visual Attention, Proceedings of the 2021 Conference of the Society of Cognitive Science, Vienna, Austria.Research Data Open Access Dopamine D2 receptor antagonism modulates antidepressant placebo effects on reward sensitivity in healthy participants(Philipps-Universität Marburg) Augustat, Nick; Lee, Eunhwi; Ahn, Woo-Young; Chuang, Li-Ching; Endres, Dominik; Müller, Erik MalteContent: Open code and data for the manuscript "Augustat, N., Lee, E., Ahn, W. Y., Chuang, L. C., Endres, D., Mueller, E.: Dopamine D2 receptor antagonism modulates antidepressant placebo effects on reward sensitivity in healthy participants". Abstract: "Although antidepressant placebo effects are well-known, their underlying mechanisms are not fully understood yet. Given that (i) depression has been related to aberrant dopamine signaling and (ii) placebo effects in Parkinson’s disease have been linked to dopamine, antidepressant placebo effects may likewise be driven by dopamine. More specifically, positive treatment expectations may lead to changes in dopamine and enhance the sensitivity for reward, which is frequently reduced in depression and anhedonia. The goal of this study was to test whether treatment expectations generally affect dopamine-related reward sensitivity in healthy individuals. In a double-blind 2x2 design with N=272 participants, we verbally induced antidepressant treatment expectations (high vs. low), crossed with oral intake of a highly selective dopamine D2/3 receptor antagonist (sulpiride 400mg) vs. placebo. Afterwards, participants performed a probabilistic selection task capturing reward sensitivity, presumably related to dopamine functioning. We performed an extensive computational model fitting procedure, including recovery and comparison of 74 different reinforcement learning models using a hierarchical Bayesian sampling method, to enable a reliable parameter estimation. We found that high treatment expectations increased learning rate in the winning model, which was parametrized by a learning rate, forgetting rate, and inverse temperature. While learning rate was not modulated by sulpiride intake, sulpiride specifically decreased inverse temperature under high treatment expectations. Higher learning rates reflect higher reward sensitivity, while higher inverse temperatures indicate more random choices. Our results thus provide evidence that antidepressant treatment expectations particularly affect reward sensitivity, which is partially modulated by dopamine."Research Data Open Access Implausible Priors in Bayesian Models of Body Ownership(Moritz Schubert, 2021-05-28) Schubert, Moritz; Endres, DominikResearch Data Open Access Integration of optic flow into the sky compass network in the brain of the desert locust(Prof. Dr. Uwe Homberg) Zittrell, Frederick; Pabst, Kathrin; Carlomagno, Elena; Rosner, Ronny; Pegel, Uta; Endres, Dominik; Homberg, UweResearch Data Open Access Integration of optic flow into the sky compass network in the brain of the desert locust (Frontiers Version)Zittrell, Frederick; Pabst, Kathrin; Carlomagno, Elena; Rosner, Ronny; Pegel, Uta; Endres, Dominik; Homberg, UweResearch Data Open Access Modeling aberrant volatility estimates in Autism Spectrum Disorder(AE Theoretische Kognitionswissenschaft) Niehaus, Haukem; Kamp-Becker, Inge; Endres, Dominik; Stroth, SannaResearch Data Open Access Modeling Reward Learning Under Placebo Expectancies: A Q-Learning Approach(2022-05-10) Augustat, Nick; Müller, Erik Malte; Endres, Dominik; Chuang, Li-Ching; Panitz, Christian; Stolz, ChristopherResearch Data Open Access Sensorimotor processes are not a source of much noise: sensorimotor and decision components of reaction timesMeibodi, Neda; Schubö, Anna; Endres, DominikResearch Data Open Access Uncertainty of treatment efficacy moderates placebo effects on reinforcement learning(Philipps-Universität Marburg) Augustat, Nick; Endres, Dominik; Müller, Erik MalteThis repository includes code and data necessary for running the online survey and task, and the analyses of the manuscript "Augustat, N., Endres, D., Müller, E. M.: Uncertainty of treatment efficacy moderates placebo effects on reinforcement learning". Abstract: The placebo-reward hypothesis postulates that positive effects of treatment expectations on health (i.e., placebo effects) and reward processing share common neural underpinnings. Moreover, experiments in humans and animals indicate that reward uncertainty increases striatal dopamine, which is presumably involved in placebo responses and reward learning. Therefore, treatment uncertainty, analogously to reward uncertainty, may affect reward learning after placebo treatment. Here, we address whether different degrees of uncertainty regarding the efficacy of a sham treatment affect reward learning. In an online between-subjects experiment with N=141 participants, we systematically varied the provided efficacy instructions before participants first received a sham treatment that consisted of listening to binaural beats and then performed a probabilistic reinforcement learning task. We fitted a Q-learning model including two different learning rates for positive (gain) and negative (loss) reward prediction errors and an inverse gain parameter to behavioral decision data in the reinforcement learning task. Our results yielded an inverted-U-relationship between provided treatment efficacy probability and learning rates for gain, such that higher levels of treatment uncertainty, rather than of expected net efficacy, affect presumably dopamine-related reward learning. These findings support the placebo-reward hypothesis and suggest harnessing uncertainty in placebo treatment for recovering reward learning capabilities.